TNX News

TenX Protocols, a DeFi Technologies Advisory Client and Venture Investment, Debuts on TSX Venture Exchange as "TNX" Following Successful $30 Million Financing

TSX-V Listing of TenX (TNX): TenX Protocols Inc. ("TenX"), a DeFi Technologies advisory client and venture portfolio company, began trading on the TSX Venture Exchange under the ticker "TNX" on December 10, 2025. Over C$33 Million Raised in 2025: TenX's go-public transaction and related...

December 10, 2025

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights

TNX

FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years

August 11, 2025Earnings